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Rheumatological disorders of autoimmune origin have relatively less prevalence in children as compared to young adults and elderly age group. Common 
rheumatological disorders in children are juvenile idiopathic 
arthritis; arthritis associated with other autoimmune and 
connective tissue diseases such as systemic lupus erythematosus 
and juvenile dermatomyositis and rheumatic fever [1]. Juvenile 
ankylosing spondylitis is rarely diagnosed only in adolescent 
males, and ankylosing spondylitis as such is considered a disease 
of young adults. Ankylosing spondylitis is one of the seronegative 
spondyloarthropathies in which, the rheumatological factor is 
usually negative. On the other hand, about 90% of persons with 
ankylosing spondylitis have HLA B27 antigen positivity [2].
Ankylosing spondylitis usually presents as chronic inflammatory 
low back pain in adolescents and adults <40 years of age, with 
insidious onset and gradual progression [3]. Many of the affected 
persons complain of increased severity of pain during rest or just after 
waking in the morning and at least partial resolution in the severity 
of pain with physical activity. Juvenile ankylosing spondylitis, in 
which the age of onset is usually <18 years, differs from the classical 
presentation of ankylosing spondylitis. It involves appendicular 
joints, such as knee and ankle joints, more commonly and is frequently 
associated with enthesitis and tarsitis. Atypical presentation in 
children often causes a significant delay in establishing the correct 
diagnosis and instituting proper management [4].
About 40% of patients with ankylosing spondylitis have ocular 
complications, and among them, anterior uveitis is the commonest one, 
followed by intermediate uveitis or pars planitis [5]. However, these 
ocular complications usually occur after the onset of musculoskeletal 
complaints. There are only a few case reports in pediatric literature 
of intermediate uveitis in juvenile ankylosing spondylitis. Hereby, 
we are presenting one rare case report of a 12-year-old boy who was 
admitted to the hospital initially with intermediate uveitis and found 
to have HLA B27 positivity. The boy also developed enthesitis, knee 
joint pain, and lower back pain, later. The novelty in this case report 
remains in the fact that intermediate uveitis presenting as an isolated 
initial clinical manifestation of juvenile ankylosing spondylitis is 
extremely rare. Thus, it explains the active collaboration and cross-
referral required between ophthalmologists and pediatricians for the 
holistic management of the child.
CASE SUMMARY
The index case is a 12-year-old boy, who was presented with acute 
onset, rapidly progressive, painless vision impairment initially in the 
right eye and subsequently in the left eye, developing over 1 week. 
At the beginning of the illness, the child also had floaters in the visual 
field bilaterally, but there was no redness, foreign body sensation, 
diplopia, or any other ocular complaints. At initial presentation, the 
child had visual acuity of only finger counting at a distance of 1 m 
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in bilateral eyes. The child did not have any fever, rash, joint pain, or 
swelling, cough, respiratory distress, oral ulcer, or clinical features 
suggestive of enthesitis or other organ system involvement.
There was no family history of any rheumatological diseases 
or history of similar vision loss in young age in any of the first or 
second-degree relatives. On detailed ophthalmological evaluation, 
the child was found to have the presence of snowball like opacities 
floating in vitreous suggesting inflammatory exudates. These 
inflammatory exudates were predominantly found near pars plana 
region (snow banking), thereby establishing the diagnosis of 
intermediate uveitis. Apart from these, there was no other retina, 
cornea, or choroidal involvement. Only aqueous flare, suggestive 
of leukocytes in the aqueous chamber, was present in the right eye.
The child was also evaluated for other systemic associations such 
as juvenile idiopathic arthritis, ankylosing spondylitis, sarcoidosis, and 
multiple sclerosis. Initially, X-ray of all major axial and appendicular 
joints, chest X-ray and magnetic resonance imaging brain were 
within normal limits. Rheumatoid factor, antinuclear antibody, and 
serum angiotensin converting enzyme level were within normal 
limits. However, the child was found to have positivity for HLA B27 
antigen. Erythrocyte sedimentation rate and serum C-reactive protein 
values were raised suggestively of systemic inflammation.
Thus, the cause of vision impairment was attributed to HLA 
B27 associated with intermediate uveitis. The child was started on 
periocular corticosteroid injection, followed by the institution of 
oral steroid (prednisolone) at 2 mg/kg/day for 2 weeks followed 
by tapering over the next 4 weeks. With this, the child showed 
significant vision improvement in the bilateral eye; after 2 weeks 
of starting steroid, visual acuity in bilateral eyes was 6/36. 
However, after stopping the oral steroids, the child developed 
right ankle pain and clinical signs suggestive of enthesitis.
Over the next 2 weeks, the child also developed low backache 
and Schober test was found to be positive at that time. Repeat X-ray 
of sacroiliac joint shows some erosion of sacroiliac joint margins 
and increased joint space which was suggestive of sacroiliitis. 
Hence, the child was started on oral naproxen and a short course 
of repeat oral prednisolone for 4 weeks, to which the child showed 
significant improvement. After tapering steroid, the child was 
started on oral methotrexate at 10 mg/m2/week and at 1 year after 
follow-up; the child had no further recurrence of symptoms. At 
6 months after follow-up, repeat visual acuity was 6/9 in the right 
eye and 6/6 in the left eye suggesting a significant improvement.
DISCUSSION
Usually, HLA B27 associated uveitis presents with sudden onset 
acute anterior uveitis in adolescents and young adults. About 80% 
of the cases are asymmetrically bilateral. The inflammation is 
usually more severe than that found in idiopathic anterior uveitis 
and often associated with a fibrinous reaction, a hypopyon or 
formation of posterior synechiae [6]. It is associated with higher 
recurrence rates than the idiopathic variety. Posterior segment 
involvement in HLA-B27 associated uveitis is an under-recognized 
phenomenon but has been shown to occur in up to 17% of patients 
with B27 associated uveitis. This may take the form of posterior 
vitritis, retinal vasculitis, papillitis, or cystoids macular edema [7].
Uveitis associated with the HLA-B27 gene may occur in the 
presence or absence of an associated systemic condition [8]. 
About 20% of patients present with the ocular symptoms as 
the first manifestations of a systemic illness such as ankylosing 
spondylitis, sarcoidosis, or multiple sclerosis which became 
evident later. Due to this, it is crucial to take a detailed history and 
to conduct a focused systemic examination of these patients [9].
The prognosis in patients with HLA-B27 associated uveitis is 
controversial. Many authors have reported no significant differences 
or, indeed, a better prognosis in patients with an HLAB27 haplotype 
than in patients with idiopathic uveitis [10]. Ankylosing spondylitis 
in the juvenile age group as such shows good response to NSAIDs 
and corticosteroids and morbidity and functional impairment can 
be significantly reduced with the institution of disease modifying 
anti-rheumatic drugs like methotrexate, as in our case [11].
CONCLUSION
The current case report demonstrates the importance of evaluation 
for HLA B27 positivity in all children with isolated intermediate 
uveitis, even if systemic and musculoskeletal examinations are 
normal. These children should be promptly treated with anti-
inflammatory agents and corticosteroids. Regular follow-up is 
also essential in these children, as a significant proportion of these 
children may develop rheumatological complaints at a later date.
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